La Doctora Rut Valdor ha encabezado, junto a su equipo y en colaboración con distintos grupos de investigación de la UMU y otros centros de investigación, un estudio que revela cómo los pericitos ...
Read moreA team of researchers at IRB Barcelona demonstrates that aneuploid cells are actively eliminated by neighbouring cells through cell competition.
Read moreThe trial evaluated the safety and efficacy of ibrilatazar (ABTL0812) combined with paclitaxel/carboplatin in 40 patients with stage III/IV squamous non-small cell lung cancer (sq-NSCLC), at 6 leading...
Read moreEl proyecto propone una estrategia basada en el estudio de AXL, una proteína implicada en la progresión tumoral, la evasión inmune y la resistencia a múltiples tratamientos oncológicos
Read moreThe project aims to understand how the metastatic microenvironment evolves over time and why it develops resistance to immunotherapy.
Read moreOlavide Neuron STX, S.L. capta un millón de eurospara impulsar el desarrollo de ONESTX-1 | Inversores como Axon Desarrollo Andalucía, Anecon Inversiones, Biomedal, Eoniq Fund y Francisco León apues...
Read moreHan demostrado que el mal control glucémico durante la progresión de la diabetes mellitus tipo 2 (DM2) conlleva un mayor riesgo de desarrollar enfermedades cardiovasculares.
Read moreOne of the biomarkers that has emerged in the last 2-3 years is Claudin18.2 (CLDN18.2). In the process of oncogenic transformation, this protein migrates to the cell surface, which makes it a potentia...
Read moreIt has been published a study in Nature Communications in which, for the first time, the transcriptomic profile of human tuberculosis lung lesions is correlated with clinical data from the same patien...
Read moreThe PREFER trial has been recognised as innovative for using oral iron molecules and targeting a particularly vulnerable population: large people with advanced heart disease, usually excluded from oth...
Read moreEste trabajo aporta evidencia de que sin-lncRNA es un regulador específico del equilibrio metabólico en células senescentes. Además, abre nuevas perspectivas para el desarrollo de estrategias que ...
Read moreThe funding will be used to advance the clinical development of SpliceBio’s lead gene therapy candidate, SB-007 for Stargardt disease, including the ongoing interventional Phase 1/2 ASTRA study and ...
Read more